Adir Sommer

Dr. Adir Sommer

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2024 in NEJM AI
Verified
Journal Article
Closed access
NDNoa Dagan
Noa Dagan
SDStav Devons-Sberro
Stav Devons-Sberro
ZPZiv Paz
Ziv Paz
LZLilach Zoller
Lilach Zoller
ASAdir Sommer
Adir Sommer
RBRan D. Balicer
Ran D. Balicer

1 February 2022 in Journal of Pediatric and Adolescent Gynecology
Verified
Journal Article
Closed access
DBDvora Bauman
Dvora Bauman
ASAdir Sommer
Adir Sommer
THTal Hamer
Tal Hamer
DNDor Noy
Dor Noy
MEMatan Elami
Matan Elami
SRShoshana Revel-Vilk
Shoshana Revel-Vilk

8 January 2016 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
YHYaron Har‐Shai
Yaron Har‐Shai
ASAdir Sommer
Adir Sommer
TGTamir Gil
Tamir Gil
JKJudit Krausz
Judit Krausz
NGNir Gal‐Or
Nir Gal‐Or
IEIrit Elmalach
Irit Elmalach

1 October 2024 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
DNDror Ben Ephraim Noyman
Dror Ben Ephraim Noyman
ASAdir Sommer
Adir Sommer
ENEfrat Naaman
Efrat Naaman
JGJavier H. Gonzalez-Lugo
Javier H. Gonzalez-Lugo
Michael MimouniMichael Mimouni
Michael Mimouni
Topic: Topical nonsteroidal anti-inflammatory drugs (NSAIDs) for management of pain in patients after photorefractive keratectomy (PRK). Clinical Relevance: Pain after PRK is a major concern for both patients and surgeons. Although evidence supports the use of NSAIDs postoperatively, no consensus exists regarding the preferred regimen. The study aimed to compare the efficacy and safety of different topical NSAIDs. Methods: This study was prospectively registered with PROSPERO (ID: CRD42023417651). A systematic search of electronic databases was performed, for randomized controlled trials reporting topical NSAIDs' outcomes of corneal re-epithelization, rescue analgesics intake, and pain in days 0 to 3 after PRK (postoperative days [PODs] 0 to 3). Studies were graded for risk of bias. Data were extracted, and standardized mean differences (SMDs) were evaluated in a network meta-analysis in accordance with the Cochrane's guidelines, to which a frequentist approach model was fitted. Transitivity was assessed using the net split method. Treatment effectiveness was ranked using forest plots based on comparison with placebo. P-scores (P) and league tables were used to examine combined direct and indirect comparisons. Results: Of 1540 studies identified, 27 were included. These encompassed 2286 patients across 11 countries, evaluating 7 distinct topical NSAIDs. At POD0, ketorolac (P 0.764), flurbiprofen (P 0.763), and bromfenac (P 0.717) were the most efficient drugs overall and displayed significantly lower pain scores than placebo. Other than that, flurbiprofen held the highest rank for reported pain throughout, significantly outperforming placebo on POD1 (P 0.874, SMD −1.19, 95% CI −1.86 to −0.52), POD2 (P 0.882, SMD −1.05, 95% CI −1.82 to −0.27), and POD3 (P 0.939, SMD −1.14, 95% CI −2.1 to −0.18). Other NSAIDs were significantly better than placebo only on POD1 and POD0. Rescue analgesic intake analysis favored indomethacin (P 0.834, SMD −0.8, 95% CI −1.33 to −0.27), ketorolac, and diclofenac. Compared with placebo, re-epithelization was slowed to different significances with all NSAIDs but flurbiprofen (P 0.991, SMD −0.7, 95% CI −1.38 to −0.03). Conclusions: Flurbiprofen was favorable in pain scores on typically painful postoperative days and re-epithelization times. However, analgesics intake, a more objective outcome, suggested superiority of other NSAIDs. Inconsistencies may be explained by the small sample size. For clinical interpretation, NSAID effect sizes should be taken into consideration.

25 April 2021 in Military Medical Research
Verified
Journal Article
Open access
PDF file
ASAdir Sommer
Adir Sommer
NMNoy Mark
Noy Mark
GKGavriel D. Kohlberg
Gavriel D. Kohlberg
RGRafi Gerasi
Rafi Gerasi
LALinn Wagnert Avraham
Linn Wagnert Avraham
DNDean Nachman
Dean Nachman
Background: Tension pneumothorax is one of the leading causes of preventable death on the battlefield. Current prehospital diagnosis relies on a subjective clinical impression complemented by a manual thoracic and respiratory examination. These techniques are not fully applicable in field conditions and on the battlefield, where situational and environmental factors may impair clinical capabilities. We aimed to assemble a device able to sample, analyze, and classify the unique acoustic signatures of pneumothorax and hemothorax. Methods: Acoustic data was obtained with simultaneous use of two sensitive digital stethoscopes from the chest wall of an ex-vivo porcine model. Twelve second samples of acoustic data were obtained from the in-house assembled digital stethoscope system during mechanical ventilation. The thoracic cavity was injected with increasing volumes of 200, 400, 600, 800, and 1000 ml of air or saline to simulate pneumothorax and hemothorax, respectively. The data was analyzed using a multi-objective genetic algorithm that was used to develop an optimal mathematical detector through the process of artificial evolution, a cutting-edge approach in the artificial intelligence discipline. Results: The in-house assembled dual digital stethoscope system and developed genetic algorithm achieved an accuracy, sensitivity and specificity ranging from 64 to 100%, 63 to 100%, and 63 to 100%, respectively, in classifying acoustic signal as associated with pneumothorax or hemothorax at fluid injection levels of 400 ml or more, and regardless of background noise. Conclusions: We present a novel, objective device for rapid diagnosis of potentially lethal thoracic injuries. With further optimization, such a device could provide real-time detection and monitoring of pneumothorax and hemothorax in battlefield conditions.

3 April 2026 in AJO International
Verified
Journal Article
Open access
GMGuy Marmur
Guy Marmur
MNMalachy Nemet
Malachy Nemet
ASAdir Sommer
Adir Sommer
AAAya Altarescu
Aya Altarescu
GBGil Ben-David
Gil Ben-David
DBDaniel Bahir
Daniel Bahir